| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |